Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborators:
Cancer Support Community
CHARLES B WANG COMMUNITY HEALTH CENTER
Queens Health Network
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01632956
First received: June 29, 2012
Last updated: February 5, 2014
Last verified: February 2014
  Purpose

There are few breast cancer support groups that focus on the specific needs of Chinese women. The purpose of this study is to learn about two different ways of providing support groups to help women of Chinese descent cope with the difficulties of a diagnosis of breast cancer and its treatment. The investigators want to learn about how best to support Chinese women with breast cancer by providing two different types of groups: an in-person support group and a virtual (online/phone) support group.


Condition Intervention
Chinese Immigrants With Breast Cancer
Behavioral: in-person support group
Behavioral: virtual support group

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer: A Pilot Study

Resource links provided by NLM:


Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • feasibility [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    To pilot and evaluate the feasibility of information-based, culturally-tailored in-person and virtual support groups for Chinese patients with breast cancer. The feasibility of participation in the in-person and virtual support groups will be measured by documenting patient accrual to the pilot study and attendance at the support groups.


Secondary Outcome Measures:
  • To compare the impact of participation [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    in the in-person versus virtual support groups on quality of life (QOL), pain, psychosocial outcomes (distress, depression, anxiety, self-efficacy in coping with cancer), and perceived social support. These outcomes will be measured through a baseline and exit Outcomes Survey.

  • To assess satisfaction with the support groups [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    All participants will complete the Brief Support Group Survey at the end of each support meeting to assess satisfaction with and to provide feedback on the usefulness of the meeting and the information presented, ease of understanding and cultural appropriateness of the information, effectiveness of the facilitator, and suggestions for change or improvement.

  • To assess Internet use [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    among support group participants. All patients approached for study participation will complete the Screening Tool, which includes questions related to Internet use. The Screening Tool will be used for all eligible patients (patients refusing to participate will still be asked to complete the screening tool).


Enrollment: 0
Study Start Date: June 2012
Estimated Study Completion Date: June 2014
Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
in-person support group
This is a 1 year pilot study of the feasibility of participation in both in-person and virtual information-based, culturally tailored support groups for Chinese breast cancer patients.
Behavioral: in-person support group
Each support group will consist of 12 sessions. Thirty-two breast cancer patients of Chinese descent will be recruited to participate in the support groups (16 in the inperson groups and 16 in the virtual groups).
virtual support group
This is a 1 year pilot study of the feasibility of participation in both in-person and virtual information-based, culturally tailored support groups for Chinese breast cancer patients.
Behavioral: virtual support group
Each support group will consist of 12 sessions. Thirty-two breast cancer patients of Chinese descent will be recruited to participate in the support groups (16 in the inperson groups and 16 in the virtual groups).

  Eligibility

Ages Eligible for Study:   21 Years to 80 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Recruitment will be conducted by the MSKCC Research Study Assistant (RSA) with the assistance of the treatment team and community partners. Patients of MSKCC and QCC will be approached in clinic waiting rooms by the RSA. ACS Asian Initiatives and the Charles B Wang Community Health Center are referral sites for this study.

Criteria

Inclusion Criteria:

  • Female
  • Non-US born
  • Resident in the US < 20 years
  • Of Chinese descent
  • Age 21 years through 80 years
  • Language spoken: Mandarin
  • Diagnosis of breast cancer within 3 months prior to recruitment

    *Not required that breast cancer is the patients' first and/or only cancer diagnosis

  • Currently receiving cancer treatment;
  • Will be living continuously in the US for the next year
  • Has a telephone that he/she is willing to use for the study

Exclusion Criteria:

  • Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection
  • Another household member is already enrolled.
  • Prior participation in a cancer support group
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01632956

Locations
United States, New York
Queens Cancer Center of Queens Hospital
Jamaica, New York, United States, 11432
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
Cancer Support Community
CHARLES B WANG COMMUNITY HEALTH CENTER
Queens Health Network
Investigators
Principal Investigator: Jennifer Leng, MD, MPH Memorial Sloan-Kettering Cancer Center
  More Information

Additional Information:
No publications provided

Responsible Party: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT01632956     History of Changes
Other Study ID Numbers: 12-105
Study First Received: June 29, 2012
Last Updated: February 5, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:
Support Groups
Breast cancer
Mandarin speaking
12-105

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on April 14, 2014